World's Best Scientists 2026 revealed!
Award Badge
Immunology
Turkey
2026

D-Index & Metrics

Immunology

D-Index
43
Citations
10143
World Ranking
4820
National Ranking
3

Sevgi Keles publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sevgi Keles sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 174 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sevgi Keles D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sevgi Keles sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Turkey Leader Award

Overview

Sevgi Keles is affiliated with Necmettin Erbakan University in Turkey, with a research focus primarily in immunology and related biomedical sciences. Their work spans several interrelated fields including Immunology and Microbiology, Medicine, and Biochemistry, Genetics and Molecular Biology. Within these domains, they have contributed extensively to subfields such as Immunology, Genetics, Infectious Diseases, Epidemiology, and Molecular Biology.

Their research covers a range of topics which include Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Immune Cell Function and Interaction, T-cell and B-cell Immunology, SARS-CoV-2 and COVID-19 Research, Diabetes and associated disorders, and COVID-19 Clinical Research Studies.

Sevgi Keles has frequently published in notable venues, reflecting a sustained engagement with high-impact platforms. These publication venues include:

  • The Journal of Experimental Medicine
  • Journal of Clinical Immunology
  • Science Immunology
  • Research Square (Research Square)
  • Frontiers in Immunology

Several recent papers demonstrate their involvement in COVID-19 and immunology research, with works published in Science, Science Immunology, and Proceedings of the National Academy of Sciences. These notable papers include:

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 (2020, Science)
  • Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021, Science Immunology)
  • X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 (2021, Science Immunology)
  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies (2022, Proceedings of the National Academy of Sciences)
  • Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children (2022, Science)

In collaboration, Keles has frequently co-authored with several researchers, including İsmail Reisli, Şükrü Nail Güner, Mehmet Ali Karaselek, Paul Bastard, and Tayfun Özçelık, reflecting a network of contributors working on related immunological and clinical subjects.

Best Publications

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome

    Karin R. Engelhardt;Sean McGhee;Sabine Winkler;Atfa Sassi

  • X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

    Takaki Asano;Bertrand Boisson;Bertrand Boisson;Bertrand Boisson;Fanny Onodi;Daniela Matuozzo;Daniela Matuozzo

  • DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

    Susanne E. Aydin;Sara Sebnem Kilic;Caner Aytekin;Ashish Kumar

  • Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like disorder caused by loss-of-function mutations in LRBA

    Louis-Marie Charbonnier;Erin Janssen;Janet Chou;Toshiro K. Ohsumi

  • Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial

    A. O. Eifan;T. Akkoc;A. Yildiz;S. Keles

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation

    Haifa H. Jabara;Douglas R. McDonald;Erin Janssen;Michel J. Massaad

  • The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.

    Karin R. Engelhardt;Karin R. Engelhardt;Karin R. Engelhardt;Michael E. Gertz;Sevgi Keles;Sevgi Keles;Alejandro A. Schäffer

  • Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

    Unknown

  • A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity

    Vivien Béziat;Vivien Béziat;Juan Li;Jian-Xin Lin;Cindy S. Ma;Cindy S. Ma

  • Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections

    Kerry Dobbs;Cecilia Domínguez Conde;Shen-Ying Zhang;Silvia Parolini

  • Anaphylaxis to multiple pollen allergen sublingual immunotherapy

    A. O. Eifan;S. Keles;N. N. Bahceciler;I. B. Barlan

  • DOCK8 deficiency: Insights into pathophysiology, clinical features and management

    Catherine M. Biggs;Sevgi Keles;Talal A. Chatila

  • Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

    Victoria Katharina Tesch;Hassan Abolhassani;Hassan Abolhassani;Bella Shadur;Bella Shadur;Joachim Zobel

  • Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

    Ayca Kiykim;Ismail Ogulur;Esra Dursun;Louis Marie Charbonnier

  • A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.

    Sevgi Keles;Elif Karakoc-Aydiner;Ahmet Ozen;Ayse Gul Izgi

  • SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Vanessa Sancho-Shimizu;Petter Brodin;Aurélie Cobat;Aurélie Cobat;Aurélie Cobat;Catherine M Biggs

  • Defects along the TH17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome

    Shadi Al Khatib;Sevgi Keles;Maria Garcia-Lloret;Elif Karakoc-Aydiner

  • Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation

    Fayhan J. Alroqi;Louis-Marie Charbonnier;Safa Baris;Ayca Kiykim

  • Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells.

    Erin Janssen;Erin Janssen;Henner Morbach;Sumana Ullas;Jason M. Bannock

Frequent Co-Authors

Talal A. Chatila
Talal A. Chatila Boston Children's Hospital
Raif S. Geha
Raif S. Geha Boston Children's Hospital
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Waleed Al-Herz
Waleed Al-Herz Kuwait University
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Bertrand Boisson
Bertrand Boisson Rockefeller University
Necil Kutukculer
Necil Kutukculer Ege University
Sung-Yun Pai
Sung-Yun Pai National Institutes of Health
Janet Chou
Janet Chou Boston Children's Hospital
Laurent Abel
Laurent Abel Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden your career options. Nursing programs, such as Licensed Practical Nurse (LPN) pathways, provide a solid foundation and are often accessible through lpn programs easy to get into. These programs allow students to quickly enter the healthcare field and gain practical experience.

Advancing further, nurse practitioner degrees offer specialized clinical training. Many students look for the easiest np program options to balance rigorous coursework with flexibility. This makes pursuing a nurse practitioner role more manageable for working professionals.

Those targeting mental health can benefit from programs like the Psychiatric Mental Health Nurse Practitioner (PMHNP) degree. Choosing one of the best online pmhnp programs ensures strong clinical placements, which are crucial for hands-on experience and job readiness.

Affordability is also key for many students. The cheapest pmhnp programs provide cost-effective paths to a rewarding career, making specialized training accessible without compromising quality.

By understanding these related pathways, Immunology students can diversify their skills, enhance employability, and make informed decisions about their education and future careers.

Best Scientists Citing Sevgi Keles

Trending Scientists

Recently Published Articles